BioAge Labs (BIOA) Cash & Equivalents (2023 - 2026)
BioAge Labs (BIOA) posted Cash & Equivalents of $241.8 million for Q1 2026, up 28.0% sequentially from $188.9 million in Q4 2025, and down 27.85% YoY from $335.1 million in Q1 2025.
BioAge Labs (BIOA) Cash & Equivalents (2023 - 2026) Analysis & Trends
BioAge Labs has reported Cash & Equivalents for 4 years, with the latest figure at $241.8 million in Q1 2026.
- Quarterly Cash & Equivalents fell 27.85% year-over-year to $241.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $241.8 million (down 27.85% YoY) and the FY2025 annual result came in at $188.9 million, down 46.65% from the prior year.
- Cash & Equivalents improved to $241.8 million in Q1 2026 per BIOA's latest filing, from $188.9 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $354.1 million in Q4 2024 and troughed at $21.6 million in Q4 2023.
- A 4-year average of $231.7 million and a median of $220.0 million in 2025 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2024 and 2025: Cash & Equivalents jumped 1535.84% in 2024, then sank 46.65% in 2025.
- Over 4 years, Cash & Equivalents stood at $21.6 million in 2023, then surged by 1535.84% to $354.1 million in 2024, then tumbled by 46.65% to $188.9 million in 2025, then grew by 28.0% to $241.8 million in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $241.8 million, $188.9 million, and $215.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 164.00 Mn |
| 10 | BioAge Labs | 436.28 Mn | 436.28 Mn | -14.23 Mn | 381.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 381.30 Mn |
| Mar 31, 2026 | 241.78 Mn |
| Dec 31, 2025 | 188.89 Mn |
| Sep 30, 2025 | 215.30 Mn |
| Jun 30, 2025 | 220.04 Mn |
| Mar 31, 2025 | 335.10 Mn |
| Dec 31, 2024 | 354.06 Mn |
| Sep 30, 2024 | 334.47 Mn |
| Mar 31, 2024 | 173.99 Mn |
| Dec 31, 2023 | 21.64 Mn |